Meta-analysis of proton pump inhibitor use and the risk of developing gastric cancer or colorectal cancer Liu, Ke; Wang, Yong-Hong; Wang, Jun; More Liu, Ke; Wang, Yong-Hong; Wang, Jun; Chen, Bing; Luo, Na; Gong, Juan Less Anti-Cancer Drugs. 34(9):971-978, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Immune checkpoint inhibitors for RET fusion non-small cell lung cancer: hopes and challenges Zhao, Lu; Zhang, Jing; Wang, Na; More Zhao, Lu; Zhang, Jing; Wang, Na; Zhang, Dou; Wang, Ziwei; Yu, Yongchao; Mei, Qingyun; Liao, Dongying; Jia, Yingjie; Kong, Fanming Less Anti-Cancer Drugs. 34(9):979-984, October 2023. Abstract Abstract Favorite PDF Permissions Buy
The effects of statin therapy on brain tumors, particularly glioma: a review Alrosan, Amjad Z.; Heilat, Ghaith B.; Al Subeh, Zeinab Y.; More Alrosan, Amjad Z.; Heilat, Ghaith B.; Al Subeh, Zeinab Y.; Alrosan, Khaled; Alrousan, Alaa F.; Abu-Safieh, Amro K.; Alabdallat, Nuwar S. Less Anti-Cancer Drugs. 34(9):985-994, October 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
STK25: a viable therapeutic target for cancer treatments? Chen, Ke-qian; Lei, Guan-lan; Ke, Bo-yi; More Chen, Ke-qian; Lei, Guan-lan; Ke, Bo-yi; Chen, Lu; Wang, Zong-bao; Wang, Shu-zhi Less Anti-Cancer Drugs. 34(9):995-1001, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis Wang, Guangxin; Gao, Xia; Sun, Zhijun; More Wang, Guangxin; Gao, Xia; Sun, Zhijun; He, Tianyou; Huang, Chaogang; Li, Shouwei; Long, Haocheng Less Anti-Cancer Drugs. 34(9):1002-1009, October 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Single-step assembly of lipid-gelatin-epigallocatechin-3-gallate hybrid nanoparticles for cancer therapy Song, Juan; Yu, Xudong; Lv, Chengzhi; More Song, Juan; Yu, Xudong; Lv, Chengzhi; Wang, Dong Less Anti-Cancer Drugs. 34(9):1010-1017, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Anlotinib reduces the suppressive capacity of monocytic myeloid-derived suppressor cells and potentiates the immune microenvironment normalization window in a mouse lung cancer model Zhao, XiangFei; Zhao, RuGang; Wen, JuYi; More Zhao, XiangFei; Zhao, RuGang; Wen, JuYi; Zhang, Xia; Wu, ShanShan; Fang, Juan; Ma, JunPeng; Zheng, Wei; Zhang, XinHong; Lu, ZeJun; Gao, LiPin; Hu, Yi Less Anti-Cancer Drugs. 34(9):1018-1024, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells Booth, Laurence; Poklepovic, Andrew; Hancock, John F.; More Booth, Laurence; Poklepovic, Andrew; Hancock, John F.; Dent, Paul Less Anti-Cancer Drugs. 34(9):1025-1034, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor receptor-1 in macrophages and tumor cells and in combination with a murine programmed cell death ligand-1-antibody activates the immune environment of murine syngeneic tumor models El Shemerly, Mahmoud; Zanini, Elisa; Lecoultre, Marc; More El Shemerly, Mahmoud; Zanini, Elisa; Lecoultre, Marc; Walker, Paul R.; Kellenberger, Laurenz; Lane, Heidi A.; McSheehy, Paul M.J. Less Anti-Cancer Drugs. 34(9):1035-1045, October 2023. Abstract Abstract Favorite PDF Permissions Buy SDC
Codelivery of ERCC2 small interfering RNA and cisplatin with macrophage-derived mimetic nanovesicles for enhanced bladder cancer treatment Zhou, Qidong; Wu, Hao; Miao, Fengze; More Zhou, Qidong; Wu, Hao; Miao, Fengze; Cao, Yirui; Liang, Lifei; Huang, Jiahua; Qian, Zhiyu Less Anti-Cancer Drugs. 34(9):1046-1057, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Selpercatinib monotherapy in a Chinese patient with RET fusion/EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report Wu, Lin; Cheng, Ying; Huang, Dingzhi; More Wu, Lin; Cheng, Ying; Huang, Dingzhi; Sun, Yuping; Zhou, Chengzhi; Zhou, Jianying; Guo, Ye; Shao, Jingxin; Zhang, Wanli; Lu, Shun Less Anti-Cancer Drugs. 34(9):1058-1064, October 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
